CYSTIFLASH
Food supplement declared in France, declaration No 2019-1-173
CYSTIFLASH (ARAGAN) is a food supplement declared in France. Status: retiré du marché le 28 July 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- ARAGAN
- Food business operator placing the product on the market
- ARAGAN
- Status
- Retiré du marché le 28 July 2024
- Form
- Gélule
- Daily dose
- 2 gélules par jour
- Directions for use
- 1 gélule le matin, 1 gélule le soir par jour
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Système urinaire
Declaration 262408, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 28 July 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Calluna vulgaris (L.) Hull | Fleur | Extrait sec aqueux | 355 mg |
| Vaccinium macrocarpon Aiton | Fruit | Extrait sec alcoolique | 295 mg |
| Citrus limon (L.) Burm. f. | Essence (épicarpe, zeste) | Pression à froid | 15 mg |
| Origanum vulgare L. | Essence (sommités fleuries) | Distillation | 15 mg |
Additives
E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. À conserver de préférence au frais. Tenir hors de portée des jeunes enfants. Ce complément alimentaire ne se substitue pas à une alimentation variée et équilibrée ni à un mode de vie sain. Ce produit est déconseillé aux enfants de moins de 6 ans, aux femmes enceintes ou allaitantes. Les personnes sous contrôle médical doivent demander conseil à leur pharmacien ou à leur médecin. Ne convient pas aux personnes allergiques à l'un des constituants. L'usage prolongé est déconseillé.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Cystiflash Aragan, declared in 2023 : different composition: 4 ingredient(s) added, 1 missing
- Cystiflash Aragan, declared in 2022, withdrawn from the market : different composition: 3 ingredient(s) added, 0 missing
Brand : ARAGAN